Jemincare
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
420号 上海, ChinaWebsite
www.jemincare.comRevenue
$6.2 MillionIndustry
About Jemincare
Jemincare Org Chart
Is Jemincare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Jemincare, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Jemincare
Earning: See what the market has to say on Jemincare recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Jemincare had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Jemincare has new funding data
Website visits: Recent activity has been detected on your website
Check if Jemincare has recently received funding, and reach out quickly before it becomes old news!
Check out if Jemincare is spiking on competitors!
Product Launch: Get notified when Jemincare launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Jemincare is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Jemincare is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Jemincare.
Jemincare Tech Stack
A closer look at the technologies used by Jemincare
Most Recent Scoops
Jemincare News & Media
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs
SHANGHAI, Dec. 26, 2023 /PRNewswire/ -- Jemincare, a leading pharmaceutical company from China, announced that its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., recently received 6 approvals of clinical trials for its innovative drugs in the field of...Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader
SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Jemincare, a leading pharmaceutical company from China, announced today that it and its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., have entered into an exclusive worldwide license agreement with Roche (SIX: RO,...Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002
SHANGHAI, Jan. 3, 2022 /PRNewswire/ -- Joint research results from Biologics of Jemincare and Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002, an anti-SARS-CoV-2 neutralizing antibody (NAb) discovered by Biologics of Jemincare is...Jemincare Announces the Exclusive License of the Kras Inhibitor to HUYABIO
SHANGHAI, Nov. 30, 2021 /PRNewswire/ -- Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Jemincare
The history of Jemincare is an honor in the development of the national pharmaceutical industry. For 20 years, Jemincare is practicing group mission and making innovations to promote the development of China's pharmaceutical industry. 1999... Read More